CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $480,338 | +230.1% | 17,634 | +169.7% | 0.00% | – |
| Q2 2023 | $145,522 | -34.5% | 6,539 | -36.2% | 0.00% | – |
| Q1 2023 | $222,022 | +57.5% | 10,251 | +47.9% | 0.00% | – |
| Q4 2022 | $141,000 | -0.7% | 6,933 | +24.9% | 0.00% | – |
| Q3 2022 | $142,000 | +21.4% | 5,551 | +16.4% | 0.00% | – |
| Q2 2022 | $117,000 | +254.5% | 4,770 | +24.0% | 0.00% | – |
| Q1 2022 | $33,000 | -52.9% | 3,847 | +10.4% | 0.00% | – |
| Q4 2021 | $70,000 | -43.5% | 3,485 | -44.2% | 0.00% | – |
| Q3 2021 | $124,000 | -11.4% | 6,242 | -1.0% | 0.00% | – |
| Q2 2021 | $140,000 | -51.0% | 6,303 | -46.1% | 0.00% | -100.0% |
| Q1 2021 | $286,000 | -6.5% | 11,698 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $306,000 | +1510.5% | 11,722 | +922.9% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 1,146 | +27.6% | 0.00% | – |
| Q2 2020 | $15,000 | +7.1% | 898 | -20.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 1,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |